Peptide Pathway Research in Canada: Scientific Review 2026
A scientific overview of retatrutide, tirzepatide, cagrilintide, tesamorelin, MOTS-C and SS-31, with separate coverage of the non-peptide compounds 5-Amino-1MQ and NAD+. Compare molecular classifications, receptor systems, published evidence and analytical documentation.
Research compounds are best distinguished by molecular identity and experimentally measured activity. The compounds covered here span receptor-binding peptides, mitochondrial peptides, an enzyme inhibitor and a redox coenzyme. They are not interchangeable, and a shared research topic does not establish equivalent activity.
Overview
Peptide research includes distinct molecular families and experimental systems. Receptor binding, intracellular signaling, membrane interactions and enzyme activity answer different scientific questions.
A peptide is a chain of amino acids linked by peptide bonds. NAD+ is a dinucleotide coenzyme, while 5-Amino-1MQ is a small-molecule inhibitor. Neither belongs to the peptide class.
For laboratories in Canada, meaningful material evaluation begins with a clearly identified compound, a traceable lot and analytical results that match the sample under review. Our Where to Buy Peptides in Canada guide explains how to assess supplier documentation and lot traceability.
Distinct Molecular Research Pathways
Classify each compound by its documented molecular properties before comparing findings across studies.
| Category | Compounds | Scientific focus |
|---|---|---|
| Multi-receptor peptides | Retatrutide; tirzepatide | GLP-1 and GIP receptor systems; retatrutide also has glucagon receptor activity. [1] [2] |
| Amylin analogue | Cagrilintide | Amylin and calcitonin receptor systems, including receptor-complex composition. [3] |
| GHRH analogue | Tesamorelin | Growth hormone–releasing hormone analogue characterization. [4] |
| Mitochondrial peptide research | MOTS-C; SS-31 | Mitochondrial sequence origin for MOTS-C; membrane and protein interactions for SS-31. [5] [6] |
| Non-peptide biochemistry | 5-Amino-1MQ; NAD+ | NNMT enzyme inhibition and coenzyme-dependent redox reactions are separate areas of investigation. [7] |
Compound Profiles and Molecular Classification
The following profiles describe molecular categories, without ranking compounds or extrapolating beyond their research context.
| Compound | Molecular class | Published research context |
|---|---|---|
| Retatrutide | Peptide receptor agonist | GLP-1, GIP and glucagon receptor activity. [1] |
| Tirzepatide | Peptide receptor agonist | GIP and GLP-1 receptor activity; signaling behavior varies with the assay. [2] |
| Cagrilintide | Modified amylin analogue | Peptide structure–activity research involving amylin and calcitonin receptor systems. [3] |
| Tesamorelin | GHRH analogue | A synthetic analogue of growth hormone–releasing hormone. [4] |
| MOTS-C | Mitochondrial-derived peptide | A 16-amino-acid peptide described from a short open reading frame within mitochondrial 12S rRNA. [5] |
| SS-31 | Synthetic tetrapeptide | A four-residue peptide investigated for cardiolipin-associated membrane and protein interactions. [6] |
| 5-Amino-1MQ | Non-peptide small molecule | Investigated as an inhibitor of nicotinamide N-methyltransferase, abbreviated NNMT. [7] |
| NAD+ | Non-peptide dinucleotide | The oxidized form of nicotinamide adenine dinucleotide, a coenzyme involved in electron-transfer reactions. |
How to Compare Research Findings
A useful comparison matches the experimental system, analytical method and endpoint. A compound name alone is insufficient.
| Research area | What to compare | What to avoid inferring |
|---|---|---|
| Receptor assays | Receptor identity, expression system, reference ligand and measured signaling endpoint. | That activity at one receptor predicts activity at another. |
| Peptide characterization | Sequence, modifications, molecular mass and chromatographic method. | That similarly named materials have the same composition. |
| Membrane studies | Lipid composition, model system and interaction measurements. | That findings from a model membrane apply to every cellular system. |
| Enzyme studies | Enzyme identity, substrate, selectivity controls and assay interference. | That one assay establishes selectivity across all enzymes. |
| Redox measurements | Chemical species, sample integrity and the specific analytical readout. | That a coenzyme measurement establishes a broader biological effect. |
Reading the Evidence in Context
The references below support specific molecular descriptions. They are not certificates for Luxara Labs materials, and they do not establish equivalence between published study materials and current catalogue lots.
| Evidence type | What it can establish | Key limitation |
|---|---|---|
| Structural characterization | Molecular architecture and interactions observed in the reported system. | A resolved structure does not capture every dynamic state. |
| Receptor or enzyme assay | Activity measured under defined laboratory conditions. | Results depend on controls, methodology and sample characteristics. |
| Cell-based experiment | A measured response in the selected cellular model. | Cell type and experimental conditions limit generalization. |
| Analytical report | Specified measurements for the submitted sample. | Coverage is limited to the tests actually performed. |
Match the Research Question to the Evidence
Define the scientific question before choosing which literature or material records to examine.
| Topic | Question | Relevant records |
|---|---|---|
| Receptor classification | Which receptors were directly evaluated? | Receptor assays and structural studies. |
| Molecular identity | Does the reported sample match the intended molecular species? | Mass data, sequence information and method details. |
| Mitochondrial research | Was the study about peptide sequence origin or membrane interaction? | Original molecular and biochemical studies. |
| Lot comparison | Were samples assessed using comparable methods? | Lot-specific reports and analytical conditions. |
Analytical Quality and Lot Documentation
Review each report on its own terms. A single percentage does not describe every property of a research material. The peptide purity standards guide provides additional context for interpreting analytical claims.
| Record | What to check | Interpretation |
|---|---|---|
| Certificate of analysis | Compound name, sample identifier, lot, report date and laboratory details. | Confirm that the report corresponds to the material being evaluated. |
| Chromatography | Method, chromatogram, peak integration and reported result. | A chromatographic area percentage is method-dependent and is not automatically mass purity. |
| Mass spectrometry | Expected and observed mass, ion assignments and method details. | Mass data support identity assessment but do not alone prove every structural feature. |
| Lot traceability | Consistent identifiers across the listing, label and report. | Traceability links documentation to a particular material lot. |
| Stability documentation | Conditions and timeframe actually evaluated. | Do not assume that evidence for one material applies to another. |
| Additional testing | Any other properties relevant to the laboratory’s requirements. | An unreported property has not been established by the report. |
Review Luxara Labs analytical reports alongside the guide to reading a certificate of analysis. The testing and transparency hub connects these records with the broader documentation framework.
Compound Listings and Supporting Records
Use individual listings to check current identifiers and available documentation. The scientific references on this page remain separate from product-specific analytical records.
Receptor Research Compounds
Additional Research Compounds
Scientific Questions and Answers
Concise explanations of the classifications and analytical concepts used throughout this guide.
Are all eight compounds peptides?
No. Retatrutide, tirzepatide, cagrilintide, tesamorelin, MOTS-C and SS-31 are peptides. 5-Amino-1MQ is a small molecule, and NAD+ is a dinucleotide coenzyme.
How do retatrutide and tirzepatide differ in receptor classification?
Retatrutide has activity at GLP-1, GIP and glucagon receptors. Tirzepatide has activity at GIP and GLP-1 receptors. These classifications do not establish identical activity in every assay.
How is cagrilintide classified?
Cagrilintide is a modified amylin analogue. Its research includes amylin and calcitonin receptor systems, so receptor-complex identity matters when interpreting findings.
What is tesamorelin?
Tesamorelin is a synthetic analogue of growth hormone–releasing hormone, commonly abbreviated GHRH.
Are MOTS-C and SS-31 interchangeable?
No. MOTS-C is a mitochondrial-derived peptide described as 16 amino acids long. SS-31 is a synthetic tetrapeptide studied in membrane and protein interaction systems.
What does NNMT mean?
NNMT stands for nicotinamide N-methyltransferase. It is the enzyme investigated in the cited 5-Amino-1MQ research.
What does NAD+ identify?
NAD+ identifies the oxidized form of nicotinamide adenine dinucleotide. It is a coenzyme, not a peptide.
Does a purity percentage confirm molecular identity?
No. Chromatographic purity and molecular identity are different analytical questions. Interpret chromatography alongside suitable identity data and the laboratory’s stated methods.
Can a published paper verify a supplier’s lot?
No. A paper describes its own study materials and methods. A separate lot requires its own corresponding analytical documentation.
What should a research material review include?
Review molecular identity, lot traceability, analytical methods, reported results and any documented stability conditions relevant to the laboratory’s requirements.
Scientific References
Links below identify original research by topic. Topic labels summarize the relevant subject rather than reproduce publication titles.
- Retatrutide: structural receptor research — PubMed record 39019866.
- Tirzepatide: GIP and GLP-1 receptor signaling — PubMed record 32730231.
- Cagrilintide: molecular development and characterization — PubMed record 34288673.
- Tesamorelin: GHRH analogue research — PubMed record 20943777.
- MOTS-C: original molecular characterization — PubMed record 25738459.
- SS-31: mitochondrial protein interaction research — PubMed record 32554501.
- 5-Amino-1MQ: NNMT inhibitor research — PubMed record 29155147.